UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 872

Sortiert nach

Targeting monocytes/macrophages in the treatment of rheumatoid arthritis

Rheumatology (Oxford, England), 2013-04, Vol.52 (4), p.590-598

2013

Link zum Volltext

Verfügbarkeit prüfen

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Annals of the rheumatic diseases, 2008-11, Vol.67 (11), p.1516-1523

2008

Link zum Volltext

Verfügbarkeit prüfen

Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients

Arthritis research & therapy, 2020-01, Vol.22 (1), p.13-13, Article 13

2020

Link zum Volltext

Verfügbarkeit prüfen

Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’

Journal of the European Academy of Dermatology and Venereology, 2018-11, Vol.32 (11), p.1950-1953

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis

Rheumatology, 2011-06, Vol.50 (6), p.1137-1147

2011

Link zum Volltext

Verfügbarkeit prüfen

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1815-1819

2012

Link zum Volltext

Verfügbarkeit prüfen

Early‐onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome

Journal of the European Academy of Dermatology and Venereology, 2020-02, Vol.34 (2), p.340-348

2020

Link zum Volltext

Verfügbarkeit prüfen

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

Annals of the rheumatic diseases, 2003-02, Vol.62 (2), p.120-126

2003

Link zum Volltext

Verfügbarkeit prüfen

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (6), p.1108-1113

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry

Annals of the rheumatic diseases, 2012-01, Vol.71 (1), p.84-87

2012

Link zum Volltext

Verfügbarkeit prüfen

In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide beta 60-74Cit which bears the immunodominant epitope of citrullinated fibrin

Immunologic research, 2015-02, Vol.61 (1-2), p.117-125

2015

Link zum Volltext

Verfügbarkeit prüfen

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

Annals of the rheumatic diseases, 2005-06, Vol.64 (6), p.913-920

2005

Link zum Volltext

Verfügbarkeit prüfen

The fibrin-derived citrullinated peptide β60–74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies

Annals of the rheumatic diseases, 2014-06, Vol.73 (6), p.1246-1252

2014

Link zum Volltext

Verfügbarkeit prüfen

In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein–Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin

Immunologic research, 2015-02, Vol.61 (1-2), p.117-125

2015

Link zum Volltext

Verfügbarkeit prüfen

Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review

Journal of the European Academy of Dermatology and Venereology, 2014-08, Vol.28 (s5), p.17-26

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion

Journal of the European Academy of Dermatology and Venereology, 2014-08, Vol.28 (s5), p.13-16

2014

Link zum Volltext

Verfügbarkeit prüfen

Twenty five year mortality and air pollution: results from the French PAARC survey

Clinical and experimental allergy, 2005-07, Vol.62 (7), p.453-460

2005

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of spondyloarthropathies in France: 2001

Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1431-1435

2005

Link zum Volltext

Verfügbarkeit prüfen

SAT0072 Performance of Patient Reported Outcomes in the Assessment of Rheumatoid Arthritis Disease Activity: The Experience of the Espoir Cohort

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.674-674

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of rheumatoid arthritis in France: 2001

Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1427-1430

2005

Link zum Volltext

Verfügbarkeit prüfen

AB0598 Does The Presence of Anti-Citrullinated Protein Antibodies Change The Presentation of Systemic Sclerosis?

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1109-1109

2016

Link zum Volltext

Verfügbarkeit prüfen

SAT0552 Management of Rheumatoid Arthritis in Remission in Current Practice : the 3P Study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A769-A769

2013

Link zum Volltext

Verfügbarkeit prüfen

AB0371 Is Switching from IV To SC Abatacept Therapy Sustainable in The Real World? 1-Year Analysis of The Prospective, International Action Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1030-1031

2016

Link zum Volltext

Verfügbarkeit prüfen

THU0066 Do Predictors of IV Abatacept Retention Depend on The Line of Rheumatoid Arthritis Treatment: 12-Month Interim Analysis of The Observational, Prospective Action Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.202-202

2016

Link zum Volltext

Verfügbarkeit prüfen

A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146

The Journal of pathology, 2005-07, Vol.206 (3), p.260-268

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 872

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(591)
Mit Volltextzugriff
(780)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(543)
Französisch
(340)
Japanisch
(67)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(347)
Humans
(319)
Life Sciences & Biomedicine
(310)
Male
(203)
Female
(191)
Rheumatology
(188)
Middle Aged
(141)
Life Sciences
(133)
Rheumatoid Arthritis
(122)
Adult
(120)
Biological And Medical Sciences
(100)
Aged
(93)
Medical Sciences
(92)
Arthritis, Rheumatoid - Drug Therapy
(66)
Human Health And Pathology
(65)
Treatment Outcome
(60)
Sciences Biologiques Et Medicales
(56)
Sciences Medicales
(55)
Diseases Of The Osteoarticular System
(51)
Prospective Studies
(50)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting monocytes/macrophages in the treatment of rheumatoid arthritis

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients

Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘PURE‐4 scale’

Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Early‐onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry

Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry

In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide beta 60-74Cit which bears the immunodominant epitope of citrullinated fibrin

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

The fibrin-derived citrullinated peptide β60–74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies

In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein–Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin

Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review

Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion

Twenty five year mortality and air pollution: results from the French PAARC survey

Prevalence of spondyloarthropathies in France: 2001

SAT0072 Performance of Patient Reported Outcomes in the Assessment of Rheumatoid Arthritis Disease Activity: The Experience of the Espoir Cohort

Prevalence of rheumatoid arthritis in France: 2001

AB0598 Does The Presence of Anti-Citrullinated Protein Antibodies Change The Presentation of Systemic Sclerosis?

SAT0552 Management of Rheumatoid Arthritis in Remission in Current Practice : the 3P Study

AB0371 Is Switching from IV To SC Abatacept Therapy Sustainable in The Real World? 1-Year Analysis of The Prospective, International Action Study

THU0066 Do Predictors of IV Abatacept Retention Depend on The Line of Rheumatoid Arthritis Treatment: 12-Month Interim Analysis of The Observational, Prospective Action Study

A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146

Suchergebnisse filtern